Title of article
Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group
Author/Authors
Frasei، Giuseppe نويسنده , , DAiuto، Giuseppe نويسنده , , Comella، Pasquale نويسنده , , Apicella، Anna نويسنده , , Thomas، Renato نويسنده , , Capasso، Imma colata نويسنده , , Bonito، Maurizio Di نويسنده , , Cartcni، Giacomo نويسنده , , Biglietto، Maria نويسنده , , Lucia، Luigi De نويسنده , , Maiorino، Luigi نويسنده , , Piccolo، Sergio نويسنده , , Bianchi، Ugo نويسنده , , DAniello، Roberta نويسنده , , Lapenta، Liliana نويسنده , , Cornella، Giuseppe نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 1999
Pages
-238
From page
239
To page
0
Abstract
With the current trend away from affirmative action programs, it is increasingly important that universities retain the African American and Latino students that they admit. In 1988 the University of Texas at Austin (UT) established the Emerging Scholars Program (ESP) to challenge highachieving students to excel in calculus and pursue mathematics, science, or engineering (MSE) majors. The university makes a special effort to recruit African Americans, Latinos, and women, but the ESP is open to any student, regardless of race or ethnicity, who is committed to excel in calculus. We analyze the influence of calculus performance on choosing a mathematics, science, or engineering major by focusing on variations by race, ethnicity, and gender and on the role of studentsʹ participation in the ESP. Findings suggest that ESP students earn higher calculus grades than non-ESP students and are more likely to enroll in the second semester of calculus. Also, earning higher calculus grades increases the likelihood that students will choose a major in mathematics, science, or engineering. These findings suggest that to increase the number of students choosing one of these majors, administrators must seek ways to increase studentsʹ participation in calculus each semester. In addition, African Americans, Latinos, and women excel in calculus if they receive appropriate academic challenges and support.
Keywords
breast cancer , cisplatin , epirubicin , paclitaxel , weekly administration
Journal title
BREAST CANCER RESEARCH & TREATMENT
Serial Year
1999
Journal title
BREAST CANCER RESEARCH & TREATMENT
Record number
23009
Link To Document